← Leaderboards
Ma Luo
University Of Manitoba
$1,721,312
Attributed
$3,442,623
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $758.8K · FY2014–24$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,442,623 · 2
By mechanism
R01$3,442,623 · 2
Top collaborators
- Frank A Plummer4 shared
- Qingsheng Li1 shared
Most similar at University Of Manitoba
Same institution · by research overlap
- Frank A Plummer$1,396,234
Others in their field
Top investigators on “Site”
- Lawrence Corey · Fred Hutchinson Cancer Center$727,416,881
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$630,131,001
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
SiteHiv-1MutationRecombinantsVaccinesVirusInnovationMacacaPeptide HydrolasesPreventVaccine CandidateCd4 Positive T LymphocytesVectorVesicular Stomatitis Indiana VirusCellsImmune ResponseAntigensLearningHiv VaccineNatural ImmunityHiv ProteasePeptidesCell MaintenanceAntigenic Diversity
Grant awards (5)
MEPCS (Multi-epitope protease cleavage sites) vaccine for protecting against SIV rectal transmission$650,156
R01 · FY2024 · AI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$712,570
R01 · FY2017 · AI · contact PI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$758,828
R01 · FY2016 · AI · contact PI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$679,120
R01 · FY2015 · AI · contact PI
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites$641,949
R01 · FY2014 · AI · contact PI